top of page
The Way Forward Is Clearer, Together.
The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.
Psychological Implications of Mastectomies in Women with Increased Risk of Breast Cancer
The decision to undergo a risk-reducing mastectomy is a profound one for women facing a high risk of breast cancer.
Women's Cancer Research Foundation
Jan 173 min read
0 comments
The Risks of Cancer in Older Women with BRCA Pathogenic Variants: How Far Have We Come?
In a recent study, investigators estimated the cumulative risks of all cancers in women from 50 to 75 years of age who were diagnosed with..
Women's Cancer Research Foundation
Feb 3, 20232 min read
0 comments
Prevention of Ovarian Cancer
Risk reduction for women who carry BRCA1/2 mutations can achieve a 95% reduced risk of ovarian cancer through a risk-reducing...
Women's Cancer Research Foundation
Jul 26, 20222 min read
0 comments
Risk of Peritoneal Cancer After Risk-Reducing Bilateral Salpingo-Oophorectomy for Women
The average lifetime risk of developing ovarian cancer risk for women who harbor a BRCA1 or BRCA2 pathogenic germline mutation is 44% & 17%
Women's Cancer Research Foundation
Jul 11, 20222 min read
0 comments
Contraceptive Use and the Risk of Ovarian Cancer Among Women With a BRCA1 or BRCA2 Mutation
Women with a BRCA1 and BRCA2 mutation have a higher lifetime risk of developing ovarian cancer.
Women's Cancer Research Foundation
Jun 15, 20222 min read
0 comments
Cancer Risks Associated with BRCA1 and BRCA2 Pathogenic Variants
In a recent study, age-specific risk estimates of cancers, excluding breast and ovarian cancer, associated with pathogenic variants in...
Women's Cancer Research Foundation
Apr 7, 20221 min read
0 comments
Breast Cancer Surveillance Following Ovarian Cancer in BRCA Mutation Carriers
Women with a BRCA 1 or 2 mutation carriers have an increased risk of developing breast cancer and ovarian cancer. However....
Women's Cancer Research Foundation
Mar 28, 20221 min read
0 comments
Oral Contraceptives May Reduce Risk of Ovarian Cancer in BRCA Carriers
Analyses showed a longer duration of contraceptive use and more recent use were associated with a greater reduction in ovarian cancer risk.
Women's Cancer Research Foundation
Oct 22, 20211 min read
0 comments
Risk of Late-Onset Breast Cancer in Genetically Predisposed Women
Germline mutations in breast cancer predispose women to develop this malignancy, but in woman 65+years, the risk is not well-defined.
Women's Cancer Research Foundation
Oct 12, 20211 min read
0 comments
Drug Boosts Survival for Women with Advanced Ovarian Cancer
Lynparza (Olaparib), a targeted cancer therapy, has recently shown a meaningful survival benefit after 5 years.
Women's Cancer Research Foundation
Aug 5, 20211 min read
0 comments
Endometrial Cancer Risk in Women Diagnosed with a Germline BRCA1 or BRCA2 Mutation
BRCA1 and BRCA2 are genes that produce proteins that help repair damaged DNA (a person’s unique genetic code).
Women's Cancer Research Foundation
Apr 7, 20212 min read
0 comments
bottom of page